Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Technological Advances
- Drivers of Growth
- Segmental Analysis
- Conclusion
Chapter 2 Market Overview
- Introduction
- Market Potential in Drug Discovery
- Supply Chain
- Raw Materials Suppliers
- Manufacturers
- Distributors
- End Users
- Porter's Five Forces Analysis
- Potential for New Entrants
- Threat of Substitutes
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Degree of Competition
- Outlook
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Animal Testing Alternatives
- Personalized Medicine
- Market Restraints
- Lack of Standardization
- Complexity of multi-Organ-on-a-Chip
- Market Challenges
- High Cost and Lack of Technical Expertise
- Few Applications in Clinical Stages
- Market Opportunities
- Partnerships within Pharmaceutical Companies
- Unexplored Tissue and Disease Models
Chapter 4 Regulatory Landscape
- U.S.
- European Union
- China
- Japan
Chapter 5 Emerging Technologies
- Takeaways
- Body-on-a-Chip
- AI and Predictive Modeling
- 3D Printing
- Automation and Continuous Monitoring
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Products and Services
- Organ Chips
- Devices
- Software
- Services
- Market Analysis by Application
- Drug Discovery and Development
- Toxicological Research
- Physiological Model Development
- Market Analysis by End User
- Biotech and Pharmaceutical Companies
- Academic and Research Institutes
- Cosmetics Companies
- Other End Users
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 7 Competitive Intelligence
- Competitive Analysis
- Partnerships
- M&A Activity
- Funding
- Patent Landscape
- Patent Review by Jurisdiction
List of Tables
Summary Table: Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
Table 1: Molecular Biology Technologies for Multi-omics Approaches
Table 2: Single-cell and Spatial Omics Technologies, 2018-2023
Table 3: Companies in the AI Single-cell Genomics and Proteomics Market
Table 4: Global Single-cell Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 5: Global Single-cell Genomics Market, by Region, Through 2029
Table 6: Global Single-cell Proteomics Market, by Region, Through 2029
Table 7: Global Single-cell Transcriptomics Market, by Region, Through 2029
Table 8: Global Single-cell Epigenomics Market, by Region, Through 2029
Table 9: Global Single-cell Genomics and Proteomics Market, by Application, Through 2029
Table 10: Global Single-cell Genomics and Proteomics Market for Oncology, by Region, Through 2029
Table 11: Global Single-cell Genomics and Proteomics Market for Stem Cell Biology, by Region, Through 2029
Table 12: Global Single-cell Genomics and Proteomics Market for Immunology, by Region, Through 2029
Table 13: Global Single-cell Genomics and Proteomics Market for Other Applications, by Region, Through 2029
Table 14: Global Single-cell Genomics and Proteomics Market, by End User, Through 2029
Table 15: Global Single-cell Genomics and Proteomics Market for Academic and Research Organizations, by Region, Through 2029
Table 16: Global Single-cell Genomics and Proteomics Market for Biopharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 17: Global Single-cell Genomics and Proteomics Market for Clinical Laboratories, by Region, Through 2029
Table 18: Global Single-cell Genomics and Proteomics Market for Applied Markets, by Region, Through 2029
Table 19: Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
Table 20: North American Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 21: North American Genomics and Proteomics Market, by Application, Through 2029
Table 22: North American Genomics and Proteomics Market, by End User, Through 2029
Table 23: European Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 24: European Genomics and Proteomics Market, by Application, Through 2029
Table 25: European Genomics and Proteomics Market, by End User, Through 2029
Table 26: Asia-Pacific Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 27: Asia-Pacific Genomics and Proteomics Market, by Application, Through 2029
Table 28: Asia-Pacific Genomics and Proteomics Market, by End User, Through 2029
Table 29: RoW Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 30: RoW Genomics and Proteomics Market, by Application, Through 2029
Table 31: RoW Genomics and Proteomics Market, by End User, Through 2029
Table 32: Top Players in the Single-cell Genomics and Proteomics Market, 2023
Table 33: Collaborations and Partnerships: Single-cell Genomics and Proteomics Market, 2021-2024
Table 34: New Product Launch: Single-cell Genomics and Proteomics Market, 2021-2024
Table 35: Expansions and Investments: Single-cell Genomics and Proteomics Market, 2021-2024
Table 36: Mergers and Acquisitions: Single-cell Genomics and Proteomics Market, 2020-2024
Table 37: Single-cell Genomics and Proteomics Market: Patent Analysis, 2018-2024
Table 38: Key Focus Areas in ESG Metrics
Table 39: Environmental Performance Initiatives in the Genomics and Proteomics Market
Table 40: Social Performance Initiatives in the Genomics and Proteomics Market
Table 41: Governance Performance Initiatives in the Genomics and Proteomics Market
Table 42: ESG Rankings for Genomics and Proteomics Companies, 2024*
Table 43: Abbreviations Used in this Report
Table 44: 10x Genomics: Company Snapshot
Table 45: 10x Genomics: Financial Performance, FY 2022 and 2023
Table 46: 10x Genomics: Product Portfolio
Table 47: 10x Genomics: News/Key Developments, 2024
Table 48: Agilent Technologies Inc.: Company Snapshot
Table 49: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 50: Agilent Technologies Inc.: Product Portfolio
Table 51: Agilent Technologies Inc.: News/Key Developments, 2023
Table 52: BD: Company Snapshot
Table 53: BD: Financial Performance, FY 2023 and 2024
Table 54: BD: Product Portfolio
Table 55: BD: News/Key Developments, 2023-2024
Table 56: Bio-Rad Laboratories Inc.: Company Snapshot
Table 57: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58: Bio-Rad Laboratories Inc.: Product Portfolio
Table 59: Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 60: Bio-Techne: Company Snapshot
Table 61: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 62: Bio-Techne: Product Portfolio
Table 63: Bio-Techne: News/Key Developments, 2022
Table 64: Bruker: Company Snapshot
Table 65: Bruker: Financial Performance, FY 2022 and 2023
Table 66: Bruker: Product Portfolio
Table 67: Bruker: News/Key Developments, 2024
Table 68: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 69: F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 70: F. Hoffman-La Roche Ltd.: Product Portfolio
Table 71: F. Hoffman-La Roche Ltd.: News/Key Developments, 2021-2022
Table 72: Illumina Inc.: Company Snapshot
Table 73: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 74: Illumina Inc.: Product Portfolio
Table 75: Illumina Inc.: News/Key Developments, 2022-2023
Table 76: Merck KGaA: Company Snapshot
Table 77: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 78: Merck KGaA: Product Portfolio
Table 79: Promega Corp.: Company Snapshot
Table 80: Promega Corp.: Product Portfolio
Table 81: Promega Corp.: News/Key Developments, 2022-2023
Table 82: Qiagen: Company Snapshot
Table 83: Qiagen: Financial Performance, FY 2022 and 2023
Table 84: Qiagen: Product Portfolio
Table 85: Qiagen: News/Key Developments, 2022-2024
Table 86: Sartorius AG: Company Snapshot
Table 87: Sartorius AG: Financial Performance, FY 2022 and 2023
Table 88: Sartorius AG: Product Portfolio
Table 89: Sartorius AG: News/Key Developments, 2024
Table 90: Standard BioTools: Company Snapshot
Table 91: Standard BioTools: Financial Performance, FY 2022 and 2023
Table 92: Standard BioTools: Product Portfolio
Table 93: Standard BioTools: News/Key Developments, 2022-2024
Table 94: Tecan Trading AG: Company Snapshot
Table 95: Tecan Trading AG: Financial Performance, FY 2022 and 2023
Table 96: Tecan Trading AG: Product Portfolio
Table 97: Tecan Trading AG: News/Key Developments, 2024
Table 98: Thermo Fisher Scientific Inc.: Company Snapshot
Table 99: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 100: Thermo Fisher Scientific Inc.: Product Portfolio
Table 101: Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
List of Figures
Summary Figure: Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
Figure 1: Types of Omics
Figure 2: Porter’s Five Forces Analysis for the Single-cell Genomics and Proteomics Market
Figure 3: Market Dynamics of Single-cell Genomics and Proteomics
Figure 4: Global Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 5: Global Single-cell Genomics Market Share, by Region, 2023
Figure 6: Global Single-cell Proteomics Market Share, by Region, 2023
Figure 7: Global Single-cell Transcriptomics Market Share, by Region, 2023
Figure 8: Global Single-cell Epigenomics Market Share, by Region, 2023
Figure 9: Global Single-cell Genomics and Proteomics Market Share, by Application, 2023
Figure 10: Global Single-cell Genomics and Proteomics Market Share, by End User, 2023
Figure 11: Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
Figure 12: North American Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 13: European Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 14: Asia-Pacific Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 15: RoW Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 16: Snapshot of ESG Pillars
Figure 17: Advantages of ESG for Companies
Figure 18: Share of Biotech Companies Providing ESG Disclosure, 2022
Figure 19: Share of ESG Disclosure Location for the Biotech Companies, 2022
Figure 20: 10x Genomics: Revenue Share, by Business Unit, FY 2023
Figure 21: 10x Genomics: Revenue Share, by Country/Region, FY 2023
Figure 22: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24: BD: Revenue Share, by Business Unit, FY 2024
Figure 25: BD: Revenue Share, by Country/Region, FY 2024
Figure 26: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 27: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 28: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 29: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 30: Bruker: Revenue Share, by Business Unit, FY 2023
Figure 31: Bruker: Revenue Share, by Country/Region, FY 2023
Figure 32: F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 33: F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 34: Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35: Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 37: Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 38: Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 39: Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 40: Sartorius AG: Revenue Share, by Business Unit, FY 2023
Figure 41: Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 42: Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 43: Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 44: Tecan Trading AG: Revenue Share, by Business Unit, FY 2023
Figure 45: Tecan Trading AG: Revenue Share, by Country/Region, FY 2023
Figure 46: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 47: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
